Gökhan Köker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gökhan Köker has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ayhan Hilmi Çekin
Antalya Eğitim ve Araştırma Hastanesi, Gastroenteroloji Kliniği, Antalya
2 shared publications - Bilgin Bahadır Başgöz
Department of Internal Medicine, Antalya City Hospital, 07080 Antalya, Turkey
2 shared publications - Seyit Uyar
Department of Internal Medicine, University of Health Sciences, Antalya Training & Research Hospital, Antalya 07058, Türkiye
2 shared publications - Yasin Şahintürk
Department of Internal Medicine, Antalya Education Research Hospital, 07080 Antalya, Türkiye
2 shared publications - Ayca Inci
Department of Nephrology, Antalya Training and Research Hospital, 07100 Antalya, Turkey
1 shared publication - Cevdet Furkan Köşker
Department of Intensive Care, Gülhane Training and Research Hospital, Ankara, Türkiye
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Guidelines vs. generative AI in CKD patient education: the role of prompt engineering and expert blinded evaluation
This study aimed to evaluate the accuracy, content quality, and readability of patient education responses related to chronic kidney disease (CKD) generated by large language models (ChatGPT-4o mini and Gemini) compared to guideline group. Fifteen frequently asked CKD-related questions were selected using global Google Trends data and posed to both AI models and guideline-based sources. Responses were anonymized and evaluated by four independent nephrology professors using the CLEAR Tool, assessing completeness, appropriateness, evidence basis, and clarity. Both AI models significantly outperformed guideline responses across all CLEAR Tool domains (p < 0.001), with ChatGPT-4o mini achieving the highest median score (21.0 [IQR: 5.0] vs. Gemini: 17.0 [IQR: 5.0], Guideline: 13.0 [IQR: 2.0]). Initial readability analysis showed that guideline responses were easier to comprehend (Flesch-Kincaid Grade Level (FKGL): 9.40; Flesch Reading Ease (FRE): 52.01) than AI-generated content (ChatGPT FKGL: 11.34, FRE: 36.17; Gemini FKGL: 9.62, FRE: 46.36). However, when a structured prompt was applied, AI responses demonstrated significant improvements in readability, reducing the required literacy level to approximately the 7th-grade (ChatGPT FKGL: 7.87, FRE: 64.23; Gemini FKGL: 7.13, FRE: 61.45). These findings highlight the potential of prompt-guided AI models to generate accurate, accessible educational content for CKD. Prompt engineering emerges as a practical tool to enhance clarity and usability, particularly for populations with limited health literacy. Integration with frameworks like Retrieval-Augmented Generation may further improve reliability and safety in digital health communication.
- 20 February 2026
- Published by Springer Nature in BMC Nephrology
- Vol. 27 (1)
Open AccessGuidelines vs. generative AI in CKD patient education: the role of prompt engineering and expert blinded evaluation
This study aimed to evaluate the accuracy, content quality, and readability of patient education responses related to chronic kidney disease (CKD) generated by large language models (ChatGPT-4o mini and Gemini) compared to guideline group. Fifteen frequently asked CKD-related questions were selected using global Google Trends data and posed to both AI models and guideline-based sources. Responses were anonymized and evaluated by four independent nephrology professors using the CLEAR Tool, assessing completeness, appropriateness, evidence basis, and clarity. Both AI models significantly outperformed guideline responses across all CLEAR Tool domains (p < 0.001), with ChatGPT-4o mini achieving the highest median score (21.0 [IQR: 5.0] vs. Gemini: 17.0 [IQR: 5.0], Guideline: 13.0 [IQR: 2.0]). Initial readability analysis showed that guideline responses were easier to comprehend (Flesch-Kincaid Grade Level (FKGL): 9.40; Flesch Reading Ease (FRE): 52.01) than AI-generated content (ChatGPT FKGL: 11.34, FRE: 36.17; Gemini FKGL: 9.62, FRE: 46.36). However, when a structured prompt was applied, AI responses demonstrated significant improvements in readability, reducing the required literacy level to approximately the 7th-grade (ChatGPT FKGL: 7.87, FRE: 64.23; Gemini FKGL: 7.13, FRE: 61.45). These findings highlight the potential of prompt-guided AI models to generate accurate, accessible educational content for CKD. Prompt engineering emerges as a practical tool to enhance clarity and usability, particularly for populations with limited health literacy. Integration with frameworks like Retrieval-Augmented Generation may further improve reliability and safety in digital health communication.
- Open Access
- 5 June 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 1-7
Reliability and validity of the Turkish version of the trust in physician scale in community-dwelling older adults
Trust is at the core of the patient-physician relationship. The Trust in Physician Scale (TPS) was specifically developed to measure such interpersonal trust and has high validity and reliability. In this study, we aimed to assess the reliability and validity of the Turkish TPS (TPS-TR) among community-dwelling older adults. This prospective study enrolled community-dwelling older adults aged 65 years and older. The TPS-TR and other scales of generalized anxiety disorder-7 scale (GAD-7), and multidimensional trust in health care systems scale (MTHCSS) subscale-1 “trust in health care providers” were administered to all participants. We assessed the internal consistency, item-total correlations, temporal stability, factor analysis, convergent and discriminant validity of TPS-TR. The study included 230 individuals. TPS-TR demonstrated high internal consistency (Cronbach’s α = 0.866) and remarkable test-retest reliability (ICC = 0.903). The lowest item-to-total correlation was observed for item 5, with a value of 0.375, which was also considered acceptable (> 0.20). TPS-TR was strongly correlated with the MTHCSS subscale-1 (p < 0.001), suggesting high convergent validity, and showed no correlation with GAD-7 (p = 0.087) indicating adequate discriminative validity. The results of our study showed that the TPS-TR has high reliability and validity in measuring the interpersonal trust of community-dwelling older adults in their physicians. Not applicable.
- 5 June 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 1-7
Open AccessReliability and validity of the Turkish version of the trust in physician scale in community-dwelling older adults
Trust is at the core of the patient-physician relationship. The Trust in Physician Scale (TPS) was specifically developed to measure such interpersonal trust and has high validity and reliability. In this study, we aimed to assess the reliability and validity of the Turkish TPS (TPS-TR) among community-dwelling older adults. This prospective study enrolled community-dwelling older adults aged 65 years and older. The TPS-TR and other scales of generalized anxiety disorder-7 scale (GAD-7), and multidimensional trust in health care systems scale (MTHCSS) subscale-1 “trust in health care providers” were administered to all participants. We assessed the internal consistency, item-total correlations, temporal stability, factor analysis, convergent and discriminant validity of TPS-TR. The study included 230 individuals. TPS-TR demonstrated high internal consistency (Cronbach’s α = 0.866) and remarkable test-retest reliability (ICC = 0.903). The lowest item-to-total correlation was observed for item 5, with a value of 0.375, which was also considered acceptable (> 0.20). TPS-TR was strongly correlated with the MTHCSS subscale-1 (p < 0.001), suggesting high convergent validity, and showed no correlation with GAD-7 (p = 0.087) indicating adequate discriminative validity. The results of our study showed that the TPS-TR has high reliability and validity in measuring the interpersonal trust of community-dwelling older adults in their physicians. Not applicable.
- Open Access
- 28 May 2025
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 26 (1) , 1-7
The assessment of the relationship between anticholinergic burden and short-term blood pressure variability
This study aimed to investigate the relationship between short-term blood pressure variability (BPV) and anticholinergic burden (ACB) in adults with hypertension. This study included 238 hypertensive patients aged 50 and older who underwent ambulatory blood pressure monitoring. The medications used by the patients were recorded, and the ACB of each medication was calculated using the ACB Scale. The BPV was assessed based on 24-hour ambulatory blood pressure measurements using three methods: standard deviation (SD), coefficient of variation of the standard deviation (SD-CoV), and weighted standard deviation (wSD), with evaluations conducted for both day-time and night-time periods. A total of 139 patients (58.40%) had no ACB score, 64 (26.89%) had an ACB score of 1, and 35 (14.71%) had an ACB score of 2 or higher. ACB scores were significantly higher among patients with heart disease, and ACB tended to increase with age. However, no statistically significant relationship was found between ACB and mean blood pressure, nocturnal blood pressure dips, or any parameters of short-term BPV including Sd, SD-CoV and wSD. No significant association was found between ACB and short-term BPV. To the best of our knowledge, this is the first study to investigate this relationship, which may inspire further research.
- 28 May 2025
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 26 (1) , 1-7
Open AccessThe assessment of the relationship between anticholinergic burden and short-term blood pressure variability
This study aimed to investigate the relationship between short-term blood pressure variability (BPV) and anticholinergic burden (ACB) in adults with hypertension. This study included 238 hypertensive patients aged 50 and older who underwent ambulatory blood pressure monitoring. The medications used by the patients were recorded, and the ACB of each medication was calculated using the ACB Scale. The BPV was assessed based on 24-hour ambulatory blood pressure measurements using three methods: standard deviation (SD), coefficient of variation of the standard deviation (SD-CoV), and weighted standard deviation (wSD), with evaluations conducted for both day-time and night-time periods. A total of 139 patients (58.40%) had no ACB score, 64 (26.89%) had an ACB score of 1, and 35 (14.71%) had an ACB score of 2 or higher. ACB scores were significantly higher among patients with heart disease, and ACB tended to increase with age. However, no statistically significant relationship was found between ACB and mean blood pressure, nocturnal blood pressure dips, or any parameters of short-term BPV including Sd, SD-CoV and wSD. No significant association was found between ACB and short-term BPV. To the best of our knowledge, this is the first study to investigate this relationship, which may inspire further research.
- Open Access
- 15 November 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (11) , 925-933
Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance
Background: To evaluate the impact of concomitant use of probiotic BB-12 in metformin-treated patients with type 2 diabetes or prediabetes on glycemic control, metformin-related gastrointestinal side effects, and treatment compliance. Methods: A total of 156 patients (mean [standard deviation] age: 50.9 [9.9 years], 74.4% females) with newly diagnosed type 2 diabetes or prediabetes were randomly assigned to receive either metformin alone (n = 84, MET group) or metformin plus Bifidobacterium animalis subsp. lactis (BB-12) probiotic (n = 72, MET-PRO group). Data on body mass index (kg/m2), fasting blood glucose (mg/dL), blood lipids, and glycated hemoglobin (HbA1c) levels were recorded at baseline and at the third month of therapy. Data on gastrointestinal intolerance symptoms and treatment noncompliance were also recorded during post-treatment week 1 to week 4. Results: MET-PRO versus MET therapy was associated with a significantly higher rate of treatment compliance (91.7% vs 71.4%, P = .001), greater reduction from baseline HbA1c values (0.9 [0.4-1.6] vs 0.4 [0-1.6] %, P < .001) and lower likelihood of gastrointestinal intolerance symptoms, including abdominal pain (P = .031 to <.001), diarrhea (P = .005 to <.001) and bloating (P = .010 to <.001). Noncompliance developed later (at least 15 days after the therapy) in a significantly higher percentage of patients in the MET group (P = .001 for 15–21 days and P = .002 for 22–28 days). Conclusion: In conclusion, the present study proposes the benefit of combining probiotics with metformin in the treatment of patients with T2D or prediabetes in terms of improved glycemic control and treatment adherence rather than correction of dyslipidemia or weight reduction. Cite this article as: Şahin K, Şahintürk Y, Köker G, et al. Metformin with versus without concomitant probiotic therapy in newly diagnosed patients with type 2 diabetes or prediabetes: A comparative analysis in relation to glycemic control, gastrointestinal side effects, and treatment compliance. Turk J Gastroenterol. 2022;33(11):925-933.
- 15 November 2022
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 33 (11) , 925-933
Open AccessMetformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance
Background: To evaluate the impact of concomitant use of probiotic BB-12 in metformin-treated patients with type 2 diabetes or prediabetes on glycemic control, metformin-related gastrointestinal side effects, and treatment compliance. Methods: A total of 156 patients (mean [standard deviation] age: 50.9 [9.9 years], 74.4% females) with newly diagnosed type 2 diabetes or prediabetes were randomly assigned to receive either metformin alone (n = 84, MET group) or metformin plus Bifidobacterium animalis subsp. lactis (BB-12) probiotic (n = 72, MET-PRO group). Data on body mass index (kg/m2), fasting blood glucose (mg/dL), blood lipids, and glycated hemoglobin (HbA1c) levels were recorded at baseline and at the third month of therapy. Data on gastrointestinal intolerance symptoms and treatment noncompliance were also recorded during post-treatment week 1 to week 4. Results: MET-PRO versus MET therapy was associated with a significantly higher rate of treatment compliance (91.7% vs 71.4%, P = .001), greater reduction from baseline HbA1c values (0.9 [0.4-1.6] vs 0.4 [0-1.6] %, P < .001) and lower likelihood of gastrointestinal intolerance symptoms, including abdominal pain (P = .031 to <.001), diarrhea (P = .005 to <.001) and bloating (P = .010 to <.001). Noncompliance developed later (at least 15 days after the therapy) in a significantly higher percentage of patients in the MET group (P = .001 for 15–21 days and P = .002 for 22–28 days). Conclusion: In conclusion, the present study proposes the benefit of combining probiotics with metformin in the treatment of patients with T2D or prediabetes in terms of improved glycemic control and treatment adherence rather than correction of dyslipidemia or weight reduction. Cite this article as: Şahin K, Şahintürk Y, Köker G, et al. Metformin with versus without concomitant probiotic therapy in newly diagnosed patients with type 2 diabetes or prediabetes: A comparative analysis in relation to glycemic control, gastrointestinal side effects, and treatment compliance. Turk J Gastroenterol. 2022;33(11):925-933.
- 2 January 2017
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 24 (3) , 61-64
Mide kanserinde güncel durum: Lokalizasyon, patoloji ve yaş
Giriş ve Amaç: Mide kanseri Dünya üzerinde en sık görülen ikinci kanser nedenli ölüm nedenidir. Batılı ülkelerde son yıllarda proksimal yerleşimli mide kanserlerinin arttığı bunun yanında distal yerleşimli mide kanseri görülme oranının düştüğü rapor edilmektedir. Son zamanlarda ülkemizde tespit edilen mide kanserlerinin yerleşimi, patolojik tipi ve görülme yaşını tespit etmek amacıyla 2010-2015 yılları arasında tanı konulan mide kanseri vakaları araştırıldı. Gereç ve Yöntem: Antalya Eğitim ve Araştırma Hastanesi ve Ankara Güven Hastanesi Gastroenteroloji Kliniklerinde 2010-2015 yılları arasında tanı almış mide kanseri vakaları retrospektif olarak araştırıldı. Toplam 203 hasta çalışmaya dahil edildi. Hastalar 2010-2013 arası 1. grup, 2013-2016 arası 2. grup olmak üzere iki gruba ayrıldı. Hastaların dosyaları retrospektif olarak incelenerek demografik özellikleri, mide kanserinin endoskopik tespit edilen yerleşimi ve patolojik değerlendirme sonuçları iki grup arasında karşılaştırıldı. Bulgular: Hastaların 126’sı (%62.1) erkek, 77’si (%37.9) kadındı. Erkek ve kadın hastaların yaş ortalamaları arasında istatistiksel fark tespit edilmedi (p>0,05). Tüm hastalar incelendiğinde toplam 203 hastanın 68’i (%33.5) proksimal, 135’i (%66.5) distal mide kanseri olarak saptandı. 2. grupta proksimal mide kanseri 1. gruba göre daha sık saptanmakla birlikte istatistiksel anlamlı düzeye ulaşmadı. Mide kanseri yerleşimleri ile hastaların yaşları ve cinsiyetleri arasında istatistiksel fark tespit edilmedi (p>0,05). 154 (%75) hastada adenokanser, 25 (%12) hastada karsinoid tümör, 15 (%8) hastada lenfoma, 9 (%5) hastada stromal tümör tespit edildi. İkinci grupta istatistiksel anlamlı olmamakla birlikte 1.gruba göre daha sık karsinoid tümör saptandı. Patolojik kanser tipleri ile yaş ve cinsiyet arasında istatistiksel olarak anlamlı bir fark bulunmadı (p>0,05). 45 yaş altı mide kanseri oranı tüm hastaların %13.5’unu oluşturmaktaydı.Sonuç: Mide kanserleri en çok mide korpusu sonra antrum ve en az sıklıkta kardiyada görülmektedir. Bulgularımız son yıllarda rapor edilen proksimal mide kanserinin distal mide kanserinden daha sık görüldüğü sonucuyla çelişmekle birlikte proksimal mide kanserinin insidansının artış eğiliminde olduğunu göstermektedir. Mide kanseri tespit edilen genç hastaların çokluğu ve hatta 20’li yaşlarda hastaların tespit edilmesi nedeniyle dispeptik hastalarda endoskopi istemlerinde yaş sınırlarının gözden geçirilmesi gerektiğini düşündürmektedir.
- 2 January 2017
- Published by Endoscopy Gastrointestinal in Endoskopi Gastrointestinal
- Vol. 24 (3) , 61-64
Mide kanserinde güncel durum: Lokalizasyon, patoloji ve yaş
Giriş ve Amaç: Mide kanseri Dünya üzerinde en sık görülen ikinci kanser nedenli ölüm nedenidir. Batılı ülkelerde son yıllarda proksimal yerleşimli mide kanserlerinin arttığı bunun yanında distal yerleşimli mide kanseri görülme oranının düştüğü rapor edilmektedir. Son zamanlarda ülkemizde tespit edilen mide kanserlerinin yerleşimi, patolojik tipi ve görülme yaşını tespit etmek amacıyla 2010-2015 yılları arasında tanı konulan mide kanseri vakaları araştırıldı. Gereç ve Yöntem: Antalya Eğitim ve Araştırma Hastanesi ve Ankara Güven Hastanesi Gastroenteroloji Kliniklerinde 2010-2015 yılları arasında tanı almış mide kanseri vakaları retrospektif olarak araştırıldı. Toplam 203 hasta çalışmaya dahil edildi. Hastalar 2010-2013 arası 1. grup, 2013-2016 arası 2. grup olmak üzere iki gruba ayrıldı. Hastaların dosyaları retrospektif olarak incelenerek demografik özellikleri, mide kanserinin endoskopik tespit edilen yerleşimi ve patolojik değerlendirme sonuçları iki grup arasında karşılaştırıldı. Bulgular: Hastaların 126’sı (%62.1) erkek, 77’si (%37.9) kadındı. Erkek ve kadın hastaların yaş ortalamaları arasında istatistiksel fark tespit edilmedi (p>0,05). Tüm hastalar incelendiğinde toplam 203 hastanın 68’i (%33.5) proksimal, 135’i (%66.5) distal mide kanseri olarak saptandı. 2. grupta proksimal mide kanseri 1. gruba göre daha sık saptanmakla birlikte istatistiksel anlamlı düzeye ulaşmadı. Mide kanseri yerleşimleri ile hastaların yaşları ve cinsiyetleri arasında istatistiksel fark tespit edilmedi (p>0,05). 154 (%75) hastada adenokanser, 25 (%12) hastada karsinoid tümör, 15 (%8) hastada lenfoma, 9 (%5) hastada stromal tümör tespit edildi. İkinci grupta istatistiksel anlamlı olmamakla birlikte 1.gruba göre daha sık karsinoid tümör saptandı. Patolojik kanser tipleri ile yaş ve cinsiyet arasında istatistiksel olarak anlamlı bir fark bulunmadı (p>0,05). 45 yaş altı mide kanseri oranı tüm hastaların %13.5’unu oluşturmaktaydı.Sonuç: Mide kanserleri en çok mide korpusu sonra antrum ve en az sıklıkta kardiyada görülmektedir. Bulgularımız son yıllarda rapor edilen proksimal mide kanserinin distal mide kanserinden daha sık görüldüğü sonucuyla çelişmekle birlikte proksimal mide kanserinin insidansının artış eğiliminde olduğunu göstermektedir. Mide kanseri tespit edilen genç hastaların çokluğu ve hatta 20’li yaşlarda hastaların tespit edilmesi nedeniyle dispeptik hastalarda endoskopi istemlerinde yaş sınırlarının gözden geçirilmesi gerektiğini düşündürmektedir.